Literature DB >> 7083772

Cardiac output measured by transthoracic impedance cardiography at rest, during exercise and at various lung volumes.

A T Edmunds, S Godfrey, M Tooley.   

Abstract

1. Cardiac output measured by transthoracic impedance cardiography has been compared with simultaneous measurements made by the indirect Fick CO2 rebreathing method in nine adults and 14 children. All were healthy normal volunteers. Sixty-six comparisons were made at rest and during steady exercise at work loads up to 100 W. 2. Impedance measurements of cardiac output were consistently higher than indirect Fick measurements of cardiac output, but after application of a correction factor related to packed cell volume there was close correlation between the results obtained by the two methods (r = 0.94). 3. The mean coefficient of variation of impedance measurements of cardiac output was 13% at rest and 5% during steady-state exercise. 4. Changes of lung volume due to breath holding or resulting from addition of an expiratory resistance did not affect the measurement of cardiac output by impedance. 5. Transthoracic impedance cardiography is a rapid, non-invasive technique for measurement of cardiac output. It requires very little active co-operation from the subject. The method would probably give reliable results for patients with respiratory illnesses such as acute asthma or bronchiolitis, during which changes of lung volume may be expected to occur.

Entities:  

Mesh:

Year:  1982        PMID: 7083772     DOI: 10.1042/cs0630107

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

1.  Haemodynamic effects of roxatidine, an H2-receptor antagonist.

Authors:  A Halabi; A Nokhodian; W Kirch
Journal:  Clin Investig       Date:  1992-02

2.  The cardiovascular effects of oral nifedipine and nicardipine: a double-blind comparison in healthy volunteers using transthoracic bioimpedance cardiography.

Authors:  S H Thomas; P Molyneux; J Kelly; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Pharmacological manipulation of cardiovascular responses to lower body negative pressure.

Authors:  G Perko; J F Schmidt; J Warberg; N H Secher
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

4.  The current status and future directions of impedance cardiography in ICU.

Authors:  H Fuller; G Raskob; H ter Keurs; R Hull
Journal:  Ann Biomed Eng       Date:  1989       Impact factor: 3.934

5.  New signal processing techniques for improved precision of noninvasive impedance cardiography.

Authors:  J H Nagel; L Y Shyu; S P Reddy; B E Hurwitz; P M McCabe; N Schneiderman
Journal:  Ann Biomed Eng       Date:  1989       Impact factor: 3.934

Review 6.  Cardiac output measurements. A review of current techniques and research.

Authors:  K C Ehlers; K C Mylrea; C K Waterson; J M Calkins
Journal:  Ann Biomed Eng       Date:  1986       Impact factor: 3.934

7.  Elimination of breathing artefacts from impedance cardiograms at rest and during exercise.

Authors:  O Eiken; P Segerhammar
Journal:  Med Biol Eng Comput       Date:  1988-01       Impact factor: 2.602

Review 8.  Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part II: Novel techniques and new advances.

Authors:  D E Warburton; M J Haykowsky; H A Quinney; D P Humen; K K Teo
Journal:  Sports Med       Date:  1999-04       Impact factor: 11.136

9.  The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease.

Authors:  Devin B Phillips; Craig D Steinback; Sophie É Collins; Desi P Fuhr; Tracey L Bryan; Eric Y L Wong; Vincent Tedjasaputra; Mohit Bhutani; Michael K Stickland
Journal:  J Physiol       Date:  2018-04-11       Impact factor: 5.182

10.  The role of pulmonary CO2 flow in the control of the phase I ventilatory response to exercise in humans.

Authors:  P Cerretelli; B Grassi; L Xi; F Schena; C Marconi; M Meyer; G Ferretti
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.